Literature DB >> 15613298

In vitro and in vivo relevance of infectious laryngotracheitis virus gJ proteins that are expressed from spliced and nonspliced mRNAs.

Walter Fuchs1, Dorothee Wiesner, Jutta Veits, Jens P Teifke, Thomas C Mettenleiter.   

Abstract

The positional homologue in the infectious laryngotracheitis virus (ILTV) genome of the glycoprotein gJ gene of herpes simplex virus and the gp2 gene of equine herpesvirus 1 is expressed into four proteins of 85, 115, 160, and 200 kDa (J. Veits, B. Kollner, J. P. Teifke, H. Granzow, T. C. Mettenleiter, and W. Fuchs, Avian Dis. 47:330-342, 2003). RNA analyses revealed that these proteins are expressed from two different late (gamma2) transcripts, an unspliced 5.5-kb and a spliced 4.3-kb mRNA that are translated into proteins of 985 and 611 amino acids, respectively. ILTV gJ is incorporated into virions and is modified by N- and O-linked glycosylation. After cotransfection of chicken cells with genomic DNA of a pathogenic ILTV strain and transfer plasmids, gJ-negative ILTV mutants could be isolated. In vitro growth studies demonstrated that deletion of the gJ gene has only minor effects on direct cell-to-cell spread as measured by plaque size. However, progeny virus titers of ILTV-DeltagJ were significantly reduced in comparison to those of the parental virus and a gJ rescue mutant. After experimental infection of chickens the gJ rescue mutant, like wild-type ILTV, caused severe disease and considerable mortality, whereas ILTV-DeltagJ was significantly attenuated. All immunized animals were protected against subsequent challenge infection with virulent ILTV. In sera collected after immunization with the gJ-rescue mutant or with wild-type ILTV, gJ-specific antibodies were detectable by immunofluorescence on cells that had been transfected with a gJ expression plasmid. As expected, no gJ-specific antibodies were found in sera obtained from chickens immunized with ILTV-DeltagJ. Thus, gJ deletion mutants of ILTV might be usable as attenuated live-virus vaccines. Furthermore, the gJ gene might constitute a reliable marker for serological discrimination between vaccinated and field virus-infected chickens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15613298      PMCID: PMC538576          DOI: 10.1128/JVI.79.2.705-716.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Toward a comprehensive phylogeny for mammalian and avian herpesviruses.

Authors:  D J McGeoch; A Dolan; A C Ralph
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Eradication of Aujeszky's disease in Germany.

Authors:  T Müller; H-J Bätza; H Schlüter; F J Conraths; T C Mettenleiter
Journal:  J Vet Med B Infect Dis Vet Public Health       Date:  2003-06

3.  Oligomeric structure of glycoproteins in herpes simplex virus type 1.

Authors:  C G Handler; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

4.  Equine herpesvirus type 1 devoid of gM and gp2 is severely impaired in virus egress but not direct cell-to-cell spread.

Authors:  Jens Rudolph; Nikolaus Osterrieder
Journal:  Virology       Date:  2002-02-15       Impact factor: 3.616

5.  Protection of chickens from lethal avian influenza A virus infection by live-virus vaccination with infectious laryngotracheitis virus recombinants expressing the hemagglutinin (H5) gene.

Authors:  D Lüschow; O Werner; T C Mettenleiter; W Fuchs
Journal:  Vaccine       Date:  2001-07-20       Impact factor: 3.641

6.  The C-terminal regions of the envelope glycoprotein gp2 of equine herpesviruses 1 and 4 are antigenically distinct.

Authors:  G S Learmonth; D N Love; J E Wellington; J R Gilkerson; J M Whalley
Journal:  Arch Virol       Date:  2002-03       Impact factor: 2.574

Review 7.  Diva vaccines that reduce virus transmission.

Authors:  J T van Oirschot
Journal:  J Biotechnol       Date:  1999-08-20       Impact factor: 3.307

8.  Five unique open reading frames of infectious laryngotracheitis virus are expressed during infection but are dispensable for virus replication in cell culture.

Authors:  Jutta Veits; Thomas C Mettenleiter; Walter Fuchs
Journal:  J Gen Virol       Date:  2003-06       Impact factor: 3.891

9.  Isolation and characterization of monoclonal antibodies against structural proteins of infectious laryngotracheitis virus.

Authors:  Jutta Veits; Bernd Köllner; Jens P Teifke; Harald Granzow; Thomas C Mettenleiter; Walter Fuchs
Journal:  Avian Dis       Date:  2003 Apr-Jun       Impact factor: 1.577

10.  Deletion of the non-essential UL0 gene of infectious laryngotracheitis (ILT) virus leads to attenuation in chickens, and UL0 mutants expressing influenza virus haemagglutinin (H7) protect against ILT and fowl plague.

Authors:  Jutta Veits; Dörte Lüschow; Katharina Kindermann; Ortrud Werner; Jens P Teifke; Thomas C Mettenleiter; Walter Fuchs
Journal:  J Gen Virol       Date:  2003-12       Impact factor: 3.891

View more
  11 in total

1.  Psittacid herpesvirus 1 and infectious laryngotracheitis virus: Comparative genome sequence analysis of two avian alphaherpesviruses.

Authors:  Dean R Thureen; Calvin L Keeler
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

2.  Genome sequence comparison of two United States live attenuated vaccines of infectious laryngotracheitis virus (ILTV).

Authors:  Yohanna Gita Chandra; Jeongyoon Lee; Byung-Whi Kong
Journal:  Virus Genes       Date:  2012-03-01       Impact factor: 2.332

3.  Biological Characteristics of Infectious Laryngotracheitis Viruses Isolated in China.

Authors:  Mi Wu; Zhifei Zhang; Xin Su; Haipeng Lu; Xuesong Li; Chunxiu Yuan; Qinfang Liu; Qiaoyang Teng; Letu Geri; Zejun Li
Journal:  Viruses       Date:  2022-05-31       Impact factor: 5.818

4.  First complete genome sequence of infectious laryngotracheitis virus.

Authors:  Sang-Won Lee; Philip F Markham; John F Markham; Ivonne Petermann; Amir H Noormohammadi; Glenn F Browning; Nino P Ficorilli; Carol A Hartley; Joanne M Devlin
Journal:  BMC Genomics       Date:  2011-04-19       Impact factor: 3.969

5.  Methylome Analysis in Chickens Immunized with Infectious Laryngotracheitis Vaccine.

Authors:  José A Carrillo; Yanghua He; Juan Luo; Kimberly R Menendez; Nathaniel L Tablante; Keji Zhao; Joseph N Paulson; Bichun Li; Jiuzhou Song
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

6.  Duck plague virus Glycoprotein J is functional but slightly impaired in viral replication and cell-to-cell spread.

Authors:  Yu You; Tian Liu; Mingshu Wang; Anchun Cheng; Renyong Jia; Qiao Yang; Ying Wu; Dekang Zhu; Shun Chen; Mafeng Liu; XinXin Zhao; Shaqiu Zhang; Yunya Liu; Yanling Yu; Ling Zhang
Journal:  Sci Rep       Date:  2018-03-06       Impact factor: 4.379

7.  Attenuated infectious laryngotracheitis virus vaccines differ in their capacity to establish latency in the trigeminal ganglia of specific pathogen free chickens following eye drop inoculation.

Authors:  Dulari S Thilakarathne; Mauricio J C Coppo; Carol A Hartley; Andrés Diaz-Méndez; José A Quinteros; Omid Fakhri; Paola K Vaz; Joanne M Devlin
Journal:  PLoS One       Date:  2019-03-28       Impact factor: 3.240

8.  Molecular characterization and antiapoptotic function analysis of the duck plague virus Us5 gene.

Authors:  Chuankuo Zhao; Tianqiong He; Yang Xu; Mingshu Wang; Anchun Cheng; XinXin Zhao; Dekang Zhu; Shun Chen; Mafeng Liu; Qiao Yang; Renyong Jia; Xiaoyue Chen; Ying Wu; Shaqiu Zhang; Yunya Liu; Yanling Yu; Ling Zhang
Journal:  Sci Rep       Date:  2019-03-19       Impact factor: 4.379

9.  Glycoprotein G (gG) production profile during infectious laryngotracheitis virus (ILTV) infection.

Authors:  Jorge Bendezu; Sandra Morales Ruiz; Ricardo Montesinos; Ricardo Choque Guevara; Aldo Rojas-Neyra; Katherine Pauyac-Antezana; Manolo Fernández-Díaz
Journal:  PLoS One       Date:  2019-08-21       Impact factor: 3.240

10.  Infectious laryngotracheitis: Etiology, epidemiology, pathobiology, and advances in diagnosis and control - a comprehensive review.

Authors:  Vasudevan Gowthaman; Sachin Kumar; Monika Koul; Urmil Dave; T R Gopala Krishna Murthy; Palanivelu Munuswamy; Ruchi Tiwari; Kumaragurubaran Karthik; Kuldeep Dhama; Izabela Michalak; Sunil K Joshi
Journal:  Vet Q       Date:  2020-12       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.